Morning Market Gainers

By: via Benzinga
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) shares jumped 39.93% to $8.06 on positive Phase 2 liver treatment results. Magal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.